Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Conferences
Videos
Webinars
Press Releases
Whitepapers
Advertising
Top Story
Point-of-Care Testing
Scout secures CARB-X grant to advance diagnostic test development
Scout, formerly Uh Oh Labs, will advance its point-of-care (POC) diagnostic test for sexually transmitted infections (STIs) with a new $1 million accelerator grant.
Featured
Collaboration
Ipsen, Skyhawk to collaborate on drug discovery for rare neurological disorders
Gene silencing and gene editing
Engineered Cas clears barrier to antiviral CRISPR therapies
Latest News
AI-powered endoscope doubles detection of high-risk esophageal lesions
April 17, 2024
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
DermTech receives delisting warning from Nasdaq
April 17, 2024
Veracyte to share bundle of genomic classifier studies at AUA 2024
April 16, 2024
Business Insights
Research and Development
Fujifilm Diosynth Biotechnologies confirms layoffs
Mergers & Acquisitions
Bruker to acquire NanoString for $392.6M
Trends and Finance
DermTech receives delisting warning from Nasdaq
Collaboration
Nightingale Health to open U.S. lab, collaborate with Englander Institute at Weill Cornell
Diagnostic Technologies
Gene silencing and gene editing
Engineered Cas clears barrier to antiviral CRISPR therapies
Artificial Intelligence
AI-powered endoscope doubles detection of high-risk esophageal lesions
Diagnostic Technologies
Veracyte to share bundle of genomic classifier studies at AUA 2024
Regulatory Approval
Roche's breast cancer CDx receives CE Mark
Diseases
Artificial Intelligence
AI-powered endoscope doubles detection of high-risk esophageal lesions
Diagnostic Technologies
Veracyte to share bundle of genomic classifier studies at AUA 2024
Regulatory Approval
Roche, Lilly Alzheimer's blood test granted FDA breakthrough device designation
Prostate Cancer
Lipid enzyme blocker renders prostate cancer cells vulnerable to PARP inhibitors in study
More from LabPulse.com
Fujifilm Diosynth Biotechnologies confirms layoffs
By
LabPulse.com staff writers
Fujifilm Diosynth Biotechnologies confirmed a restructure that will result in the layoff of 240 employees.
April 19, 2024
Nightingale Health to open U.S. lab, collaborate with Englander Institute at Weill Cornell
By
LabPulse.com staff writers
Preventive healthcare company Nightingale Health will open a laboratory in the U.S. In addition, the Englander Institute for Precision Medicine at Weill Cornell Medicine has signed on as its first customer.
April 17, 2024
Co-Diagnostics opens manufacturing facility in Utah
By
LabPulse.com staff writers
Molecular diagnostics firm Co-Diagnostics has opened a new manufacturing facility in South Salt Lake, UT, holding a ribbon-cutting event to inaugurate the facility on April 11.
April 16, 2024
Babson adds hand-warming to blood testing mini-draws in Texas pharmacies
By
LabPulse.com staff writers
Austin, TX-based Babson Diagnostics said it has received positive feedback for its hand-warmer, which is used as part of a finger-stick blood sample collection device in retail pharmacies.
April 16, 2024
OraSure discloses cybersecurity breach
By
LabPulse.com staff writers
OraSure Technology disclosed a cybersecurity incident involving data theft that occurred in late March.
April 15, 2024
Roche, Lilly Alzheimer's blood test granted FDA breakthrough device designation
By
LabPulse.com staff writers
The Alzheimer's blood test developed through a collaboration between Roche and Lilly has been granted a breakthrough device designation by the U.S. Food and Drug Administration (FDA).
April 11, 2024
Lipid enzyme blocker renders prostate cancer cells vulnerable to PARP inhibitors in study
By
Nick Paul Taylor
Blocking lipid synthesis enhanced the effect of PARP inhibitors on prostate cancer in a preclinical study, pointing to a potential way to make the treatments effective in more patients.
April 15, 2024
European Commission approves Illumina's plan to divest Grail
By
LabPulse.com staff writers
The European Commission has approved Illumina's plan to divest multicancer early detection test maker Grail under the European Union Merger Regulation adopted by the EC in October 2023.
April 12, 2024
Roche's breast cancer CDx receives CE Mark
By
LabPulse.com staff writers
Roche has received the CE Mark for the first companion diagnostic (CDx) test to identify patients with HER2-low metastatic breast cancer who may be eligible for treatment with Enhertu.
April 10, 2024
Labcorp expands precision oncology offerings
By
Matt Limb
Laboratory services firm Labcorp has announced the expansion of its precision oncology portfolio, aimed at supporting clinical research and advancing drug development programs.
April 12, 2024
Urine test halves use of invasive procedure to monitor bladder cancer
By
Nick Paul Taylor
A urine test can cut the number of cystoscopies necessary to follow up high-risk bladder cancer patients without increasing the risk of recurrence, a study has found.
April 11, 2024
Researchers tweak TB treatment assay to support global use
By
Nick Paul Taylor
Researchers have developed a tuberculosis (TB) treatment assay that could be a faster, simpler method for monitoring patients.
April 10, 2024